Drug Shortage Report for 2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION
| Report ID | 257772 |
| Drug Identification Number | 02538644 |
| Brand name | 2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION |
| Common or Proper name | dsdsdsd |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | CALCIUM GLUCONATE |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | ewewe |
| ATC code | B05XA |
| ATC description | |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2020-01-01 |
| Actual start date | |
| Estimated end date | 2023-03-03 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-11-22 | French | Compare |
| v1 | 2025-11-22 | English | Compare |
Showing 1 to 2 of 2